Iliopsoas hematoma associated with low-molecular-weight heparin use: A case report
Iliopsoas hematoma is an uncommon clinical entity that may develop in association with anticoagulation states, coagulopathies and hemodialysis, or anticoagulant therapy. Here, we report a case of unilateral iliopsoas hematoma in a 60-year-old man who received low-molecular-weight heparin for anticoa...
Main Authors: | Shangxiang Liu, Chengqing Mei, Hui Zou, Xiaoliang Chang, Zhenglong Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-06-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X20931680 |
Similar Items
-
Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
by: Gianluca Sottilotta, et al.
Published: (2021-05-01) -
Iliopsoas Muscle Hematoma with Femoral Nerve Palsy during Treatment with Low Molecular Weight Heparin
by: A-reum Jung, et al.
Published: (2016-06-01) -
Ultrasound therapy in iliopsoas hematoma
by: Başak Bilir Kaya, et al.
Published: (2017-08-01) -
Case Report: Spontaneous Intramural Hematoma of the Colon Secondary to Low Molecular Weight Heparin Therapy
by: Ye Zhu, et al.
Published: (2021-05-01) -
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
by: Hitesh Taleja, et al.
Published: (2021-09-01)